These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 2868581
1. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy]. Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E. Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581 [Abstract] [Full Text] [Related]
2. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany]. Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E. Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859 [Abstract] [Full Text] [Related]
7. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. McCullough AJ. Am J Med; 1986 Oct 24; 81(4B):17-24. PubMed ID: 2877570 [Abstract] [Full Text] [Related]
9. Famotidine in the management of duodenal ulcer: experience in Italy. Barbara L, Corinaldesi R, Bianchi Porro G, Lazzaroni M, Blasi A, Mangiameli A, Carratelli L, Wilkins A, Cheli R, Bovero E. Digestion; 1985 Oct 24; 32 Suppl 1():24-31. PubMed ID: 2866133 [Abstract] [Full Text] [Related]
10. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. Bianchi Porro G. Digestion; 1985 Oct 24; 32 Suppl 1():62-9. PubMed ID: 2866137 [Abstract] [Full Text] [Related]
11. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial]. Delvaux M, Hagège CG, Ribet A. Gastroenterol Clin Biol; 1989 Dec 24; 13(12):1055-9. PubMed ID: 2696659 [Abstract] [Full Text] [Related]
15. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. Freston JW. Am J Gastroenterol; 1987 Dec 24; 82(12):1242-9. PubMed ID: 2891294 [Abstract] [Full Text] [Related]
16. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients. Lezoche E, Vagni V, D'Alessandro MD, Mariani P, Carlei F, Lomanto D, Nardovino M, Martelli A, Speranza V. Drugs Exp Clin Res; 1987 Dec 24; 13(10):655-8. PubMed ID: 2892658 [Abstract] [Full Text] [Related]
17. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration. Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G. Am J Gastroenterol; 1988 Jun 24; 83(6):643-5. PubMed ID: 2897784 [Abstract] [Full Text] [Related]
19. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists. Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL. J Int Med Res; 1989 Jun 24; 17 Suppl 1():25A-31A. PubMed ID: 2566541 [Abstract] [Full Text] [Related]
20. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide. Reynolds JC. Clin Ther; 1988 Jun 24; 10(4):436-49. PubMed ID: 3079011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]